Dynamic Models of Meningococcal Carriage, Disease, and the Impact of Serogroup C Conjugate Vaccination
Open Access
- 1 July 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 162 (1), 89-100
- https://doi.org/10.1093/aje/kwi160
Abstract
Much interest has surrounded the use of conjugate vaccines in recent years, with the development of vaccines against disease caused by Haemophilus influenzae type b, Neisseria meningitidis, and Streptococcus pneumoniae. These vaccines offer the potential for safe and effective disease control, but some questions remain, particularly regarding the duration and mechanisms of protection and the longer-term impact of vaccination on carriage. In this paper, the authors use data on immunization with serogroup C meningococcal conjugate vaccines in England and Wales to develop and apply a mathematical model to investigate the direct and indirect (herd immunity) effects of a conjugate vaccine program. A realistic, age-structured, dynamic model was developed and parameterized and was fitted to epidemiologic data from England and Wales. The effects of a range of vaccine strategies, including hypothetical scenarios, were investigated. The basic reproduction number was estimated to be 1.36. Catch-up vaccination targeting teenagers generated substantial herd immunity and was important in controlling disease rapidly. The results were sensitive to changes in the assumptions regarding the method of vaccine action, particularly duration of protection and efficacy of vaccination against carriage acquisition. This model can be used to help predict the potential impact of vaccine strategies both in the United Kingdom and elsewhere.Keywords
This publication has 19 references indexed in Scilit:
- Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introductionThe Lancet, 2004
- Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysisBMJ, 2003
- Economic Evaluation of Vaccination Programs: The Impact of Herd-ImmunityMedical Decision Making, 2003
- Antibody Persistence and Immunological Memory at Age 4 Years after Meningococcal Group C Conjugate Vaccination in Children in the United KingdomThe Journal of Infectious Diseases, 2002
- Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccinationThe Lancet, 2002
- Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in EnglandThe Lancet, 2001
- Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspectiveStatistics in Medicine, 1999
- The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamicaEpidemiology and Infection, 1987
- Carriage of Neisseria meningitidis and Neisseria lactamica in Infants and ChildrenThe Journal of Infectious Diseases, 1978
- HUMAN IMMUNITY TO THE MENINGOCOCCUSThe Journal of Experimental Medicine, 1969